Finding needles in haystacks: OMass unveils pipeline aimed at tough-to-drug targets

Published

November 17, 2021

Finding needles in haystacks: OMass unveils pipeline aimed at tough-to-drug targets
MORERelated News
Finding needles in haystacks: OMass unveils pipeline aimed at tough-to-drug targets
Is big pharma falling back in love with small molecules?
New approaches to small-molecule design allow difficult targets to be addressed, such as the G protein-coupled receptors (GPCR) on cell...
Women in Bio: OMass Taps Biogen Vet Nathalie Franchimont for Board of Directors
When U.K.-based OMass Therapeutics began the search for a new member for its board of directors, Chief Executive Officer Rosamond...